[{"Assets_0_Q2_USD":141219000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-50388000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1787000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1787000.0,"StockholdersEquity_0_Q2_USD":123567000.0,"Ticker":"RIGL","CIK":"1034842","name":"RIGEL PHARMACEUTICALS INC","OfficialName":"Rigel Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"488447519.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]